【摘要】：目的:研究中醫(yī)藥對復(fù)蘇后綜合征的患者的作用與療效。方法:選取80例心肺復(fù)蘇術(shù)后符合納入標(biāo)準(zhǔn)的患者,隨機分為對照組和試驗組,每組40例,對照組按照《2010國際心肺復(fù)蘇指南》組織搶救,試驗組在此基礎(chǔ)上同時給予參附注射液+血必凈注射液治療。結(jié)果:兩組在各項生理指標(biāo)以及評分系統(tǒng)上均有改善趨勢。與對照組比較,試驗組在APACHE-Ⅱ評分上的下降更加明顯(P0.05),7天生存率明顯提高。乳酸的變化提示兩組均呈下降趨勢(P0.05,P0.01),試驗組可明顯改善CA患者ROSC后的灌注情況。結(jié)論:溫陽活血法與西藥聯(lián)合使用與單純的西醫(yī)治療相比,能更好的保護肝腎功能及心肌,對復(fù)蘇后綜合征的治療有一定效果。
[Abstract]:Objective: to study the effect and effect of traditional Chinese medicine (TCM) on patients with postresuscitation syndrome. Methods: 80 patients who met the inclusion criteria after cardiopulmonary resuscitation were randomly divided into two groups: control group (n = 40) and experimental group (n = 40). The control group was treated according to < 2010 international cardiopulmonary resuscitation guidelines]. The experimental group was treated with Shenfu injection Xuebijing injection at the same time. Results: there was an improvement trend in physiological indexes and scoring system between the two groups. Compared with the control group, the APACHE- 鈪，

本文編號：2315397